Archive for the ‘Arthritis’ Category
Thursday, March 11th, 2010
Betty Isaacs of Boone, N.C., knows all about the chronic pain of osteoarthritis and the impact it has on her life. "The pain in my knee was so bad, I would just sit around," Isaacs said. Last year, Isaacs participated in the Walk with Ease program administered through the UNC Thurston Arthritis Research Center and developed by the Arthritis Foundation...
Thursday, March 11th, 2010
Christopher Evans, PhD, director of the Center for Advanced Orthopaedic Studies at Beth Israel Deaconess Medical Center (BIDMC) and Maurice Edmond Mueller Professor of Orthopaedic Surgery at Harvard Medical School, were presented with the 2010 Arthur Steindler Award at this week's annual meeting of the Orthopaedic Research Society in New Orleans...
Thursday, March 11th, 2010
While physicians strive to set realistic expectations for patients undergoing knee and hip joint replacements, a new study reveals that doctor and patient expectations are sometimes not aligned...
Friday, March 5th, 2010
NICE's independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product...
Thursday, March 4th, 2010
The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE's provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS's successful appeal of negative NICE guidance on switching in 2007...
Thursday, March 4th, 2010
Today the Arthritis and Musculoskeletal Alliance (ARMA), backed by leading policymakers and employers, is calling for positive action to ensure people with musculoskeletal disorders (MSDs) are properly supported to access employment and remain in their jobs...
Thursday, March 4th, 2010
The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 and 141...
Wednesday, March 3rd, 2010
BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in late February...
Tuesday, March 2nd, 2010
New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified...
Friday, February 26th, 2010
A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D...
Friday, February 26th, 2010
Researchers from the Toronto Western Research Institute noted a higher prevalence of arthritis and arthritis-attributable activity limitations (AAL) in the U.S. versus the Canadian population. The authors attribute the higher prevalence of arthritis and AAL to a greater level of obesity and physical inactivity in Americans, particularly women...
Thursday, February 25th, 2010
Final guidance published today (Wednesday 24 February 2010) by the National Institute for Health and Clinical Excellence (NICE) means that another drug - certolizumab pegol (Cimzia) - can be considered for some people in England and Wales suffering with rheumatoid arthritis...
Tuesday, February 23rd, 2010
CEL-SCI Corporation (NYSE CVM) and their scientific collaborators announced that the Company's CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model...
Tuesday, February 23rd, 2010
Enbrel is the trade name for Etanercept, a medication used for treating autoimmune diseases. Enbrel is a TNF (tumor necrosis factor) inhibitor; it interferes with TNF...
Saturday, February 20th, 2010
At the core of the American College of Rheumatology Research and Education Foundation's mission is to attract the best and brightest trainees into a career in rheumatology. To do this, the REF has an extensive portfolio of awards and grants that provide support during critical career stages...
Friday, February 19th, 2010
Contrast-enhanced magnetic resonance imaging (MRI) may help physicians differentiate between rheumatoid arthritis and psoriatic arthritis in the hand and wrist enabling more targeted therapies unique to each condition, according to a study in the March issue of the American Journal of Roentgenology . Contrast-enhanced MRI uses contrast media to improve the visibility of internal bodily structures...
Tuesday, February 16th, 2010
"Progressive walking" combined with glucosamine sulphate supplementation has been shown to improve the symptoms of osteoarthritis...
Monday, February 15th, 2010
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients. Among more specialized hospitals, there were fewer serious post-surgical complications such as blood clots, infections and heart problems, as well as fewer deaths...
Saturday, February 13th, 2010
Clinical testing and development of novel therapies based on advances in tissue engineering and regenerative medicine that will one day enable the repair and replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models...
Wednesday, February 10th, 2010
A controlled study by a group of German investigators published in the current issue of Psychotherapy and Psychosomatics indicates that brief group psychotherapy is helpful for clearing fears of disease progression (FoP) in patients with chronic arthritis or cancer. The interventions comprised either cognitive-behavioral group therapy or supportive-experiential group therapy...
Friday, February 5th, 2010
Hospital for Special Surgery, (HSS), a world leader in orthopedics and rheumatology, announced its support of the Arthritis Foundation and Ad Council newly launched campaign, "Moving is the Best Medicine," to raise awareness of osteoarthritis, increase public health education and support breakthrough research...